Explorations of an intramolecular route to pyrrolo[3,4-b]isoxazoles: an unexpected retro-Claisen reaction by Ray Jones (1249197) et al.
General Papers  ARKIVOC 2013 (iii) 00-00 
Page 1 ©ARKAT-USA, Inc 
Explorations of an intramolecular route to pyrrolo[3,4-b]isoxazoles: 
an unexpected retro-Claisen reaction 
 
Raymond C. F. Jones,* Carole C. M. Law, and Mark R. J. Elsegood 
 
Department of Chemistry, Loughborough University, Loughborough, Leics., LE11 3TU, UK 
E-mail: r.c.f.jones@lboro.ac.uk  
 
 
Abstract 
Potential precursors have been prepared for intramolecular 1,3-dipolar cycloaddition to form a 
pyrrolo[3,4-b]isoxazole. The cycloaddition has not to date been accomplished, however an 
unexpected retro-Claisen reaction is reported. 
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Introduction    
 
We have reported over a number of years on synthetic approaches to the 3-acyltetramic acid 
group of metabolites, which display an N-heterocyclic enolised tricarbonyl core, as illustrated in 
general structure 1 (Figure 1).1 These metabolites show a range of biological activities, ranging 
through antibiotic, antitumour, antifungal and antiviral;2 they also have a relationship to the 
inducers of bacterial quorum sensing.3 Over recent years we have focussed on pyrroloisoxazoles 
2 and 3 as providing masked forms of the polar enol functionality in the acyltetramic acids.4-6 
 
 
 
Figure 1. General structure of 3-acyltetramic acids 1, and pyrroloisoxazole masked forms 2 & 3. 
 
Most recently we have reported on our 2nd generation approach that employs the 5,6-
dihydropyrrolo[3,4-b]isoxazol-4-one building block 2 through the route shown in Scheme 1, 
which involves the 1,3-dipolar cycloaddition of an amino acid-derived nitrile oxide dipole with a 
β-ketoester enamine as dipolarophile.5 One of the less efficient steps in this sequence is the ring 
closure (lactam formation) of 3-(1-aminoalkyl)-5-methylisoxazole-4-carboxylates to complete 
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the pyrroloisoxazole framework 2. We were interested to investigate whether this sequence could 
be improved by reversing the order of N1-C2 bond formation and cycloaddition, making the 
amide bond first, which would also have the possible benefit of making the cycloaddition 
intramolecular. We report here our efforts to date, which generated an intermediate having a 
nitro group as dipole precursor and a β-keto amide as dipolarophile precursor, but revealed an 
unexpected retro-Claisen reaction on attempting to generate the dipolarophile. 
 
 
 
Scheme 1. 2nd Generation isoxazole route to acyltetramic acids. Reagents: i, DIBAL-H, toluene, 
–78 oC; ii, NH2OH.HCl, NaOAc, EtOH aq., 70 oC; iii, N-chlorosuccinimide, CHCl3, reflux; iv, 
Et3N; v, TFA, 20 oC; 2M HCl; vi, EDCI, N-hydroxysuccinimide, DMF, 0→20 oC. 
 
 
Results and Discussion    
Authors, please provide missing symbols 
As the desired dipolarophile in the cycloaddition is an enamine prepared from a β-keto acid 
derivative, an obvious initial approach based on intermediates we had in hand was N-
acetoacetylation of an amino acid-derived oxime. The nitrile oxide dipole would be prepared 
from the aldoxime via C-chlorination and 1,3-dehydrochlorination. Using valine as our test 
amino acid scaffold, the aldoxime 4a was prepared from N-tert-butyloxycarbonyl-S-valine 
methyl ester (DIBAL-H, toluene, –78 °C, 2 h; then NH2OH.HCl, NaOAc, EtOH aq, 70 °C, 10 
min) in 89% yield as a 2:1 mixture of geometric isomers (Scheme 2). Acetoacetylation was 
attempted using 2,2,6-trimethyl-1,3-dioxin-4-one, the diketene-acetone adduct (PPTS, toluene 
reflux, 3 h).7 The results were inconsistent, with product 1H NMR spectra sometimes showing 
loss of the tert-butyloxycarbonyl group and sometimes not. Samples retaining the tert-
butyloxycarbonyl group had 1H NMR spectra that implied acylation of the oxime N-atom rather 
than the amine function, with a signal for the proton NHBoc being observed at δ 4.62 (1H, d, J 
9.6 Hz). More surprisingly, the NMR spectra suggested the reduced structure 5a, having an 
unexpected additional CH2N signal (δ 4.11-4.24, 2H, m; δC 65.6) and no oxime sp2-CHN 
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signals, although we were unable to fully characterise this material. A test with FeCl3 supported 
the assignment of a hydroxamate structure.8 The capricious behaviour in the thermolysis led us 
to switch to the corresponding N-benzyloxycarbonyl aldoxime 4b, prepared from N-
benzyloxycarbonyl-S-valine methyl ester as outlined above for the tert-butyloxycarbonyl 
compound 4a. Thermolysis with the diketene-acetone adduct, however, again gave a product 
assigned as the hydroxamate 5b, showing δ 3.62-3.68 (1H, m, CHNHZ), 4.07-4.17 (2H, m, 
CHCH2N), 4.62 (1H, d, J 9.6 Hz, CHNHZ), δC 67.0 (CH2N), and no oxime CH signal. Again, 
full characterisation could not be accomplished. A redox process is clearly implicated alongside 
these acylations, but we are unable to identify the reducing agent. Changing the acetoacetylating 
agent to the more reactive diketene but omitting the acid (toluene reflux, 3 h) led to the same 
presumed hydroxamates 5a,b from the aldoximes 4a,b, respectively. 
 
 
 
Scheme 2. Attempted acetoacetylation of α-amino oximes. Reagents: i, DIBAL-H, toluene, –78 
oC; ii, NH2OH.HCl, NaOAc, EtOH aq., 70 oC; iii, 2,2,6-trimethyl-1,3-dioxen-4-one, pyrH+–OTs, 
toluene reflux; or diketene, toluene reflux. 
 
These results led us to avoid the oxime as a precursor functional group for the nitrile oxide 
dipole. Instead we targeted the dehydration of a primary nitro group as the route to the nitrile 
oxide. Our target thus became an N-protected S-2-methyl-1-nitromethyl-1-propanamine 6a or 6b 
(Scheme 3), which could be N-acetoacetylated. Thus S-valinol 7 (prepared by reduction of S-
valine: TMSCl, NaBH4, THF, 0 °C, 24 h;9 78%) was selected as starting material. A good 
leaving group was now needed at the alcohol function for substitution to generate a primary nitro 
group, but attempted toluene-4-sulfonylation (TsCl, DCM, 0→20 °C, 17 h) unsurprisingly 
afforded the N-sulfonylated compound 8 (100%) rather than the desired O-sulfonylated 
compound. Thus S-valinol 7 was N-protected as the tert-butyloxycarbonyl derivative 9a (Boc2O, 
Et3N, DCM, 0→20 °C, 17 h; 100%) and benzyloxycarbonyl derivative 9b (PhCH2OCOCl, 
NaHCO3, EtOAc-H2O, 0→20 °C, 17 h; 90%). The corresponding mesylate derivatives 10a and 
10b were formed by a standard method (methanesulfonyl chloride, Et3N, DCM, 0→20 °C, 4 h) 
in crude yields of over 90%. Attempts to use these crude materials in a nucleophilic substitution 
with nitrite were unsuccessful (NaNO2, toluene or DMF, 0→60 °C, 17 h) with the alcohols 9a 
and 9b being recovered after aqueous workup. The mesylates were instead treated under 
Finkelstein conditions (NaI, acetone reflux, 17 h) in an attempt to generate the corresponding 
iodo compounds 11a and 11b, respectively. The N-tert-butyloxycarbonyl derivative 10a 
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however, underwent protecting group cleavage to afford the cyclic carbamate 12; the N-
benzyloxycarbonyl compound 10b did give the iodo compound 11b (42%) along with some 
cyclic carbamate 12 (7%). It is assumed that anchimeric assistance by the N-protecting group 
carbonyl oxygen atom is followed by loss of a carbenium ion (to afford the cyclic carbamate) 
competing with iodide nucleophilic attack. In an alternative direct iodination from alcohol 9a, 
iodotriphenylphosphonium iodide was prepared (triphenylphosphine, iodine, DCM) to which 
imidazole and alcohol 9a was added and the mixture heated under reflux for 17 h to afford the 
iodide 11a (31% after chromatography). The yield and product purification was improved by 
replacing the triphenylphosphine with a polymer-supported triphenylphosphine,10 to afford the 
iodides 11a (43%) and 11b (80%) from the corresponding alcohols 9a and 9b, respectively. 
Traces of the cyclised by-product 12 were sometimes observed in these reactions. The nitro 
substitution was undertaken with the iodo compounds, now using sodium nitrite in DMF (20 °C, 
20 h) with the addition of phloroglucinol and urea to minimize the formation of nitrite ester.11 
The corresponding N-tert-butyloxycarbonyl and N-benzyloxycarbonyl S-2-methyl-1-
nitromethylpropanamines 6a (64%) and 6b (70%) were isolated along with small recoveries of 
the corresponding alcohols 9a or 9b. 
 
 
 
Scheme 3. Preparation of protected S-2-methyl-1-nitromethylpropanamines 6. Reagents: i, TsCl, 
DCM, 0→20 °C; ii, For 9a: Boc2O, Et3N, DCM, 0→20 °C. For 9b: PhCH2OCOCl, NaHCO3, 
EtOAc-H2O, 0→20 °C; iii, MsCl, Et3N, DCM, 0→20 °C; iv, NaI, acetone reflux; v, PS-PPh3, I2; 
then imidazole; vi, NaNO2, DMF, phloroglucinol, urea, 20 °C. 
 
This route to optically active N-protected S-2-methyl-1-nitromethylpropanamines was 
complemented by a reported approach to the N-tert-butyloxycarbonyl R-compound 6c via the 
aza-Henry reaction (Scheme 4).12 Thus, sodium benzenesulfinate in water was added to tert-
butyl carbamate (THF, 20 °C), followed by 2-methylpropanal and methanoic acid. After 17 h, 
the white precipitate was recrystallized to afford the sulfone 13 (75%). Reaction with 
nitromethane in the presence of potassium hydroxide (toluene, –78→20 °C, 48 h) and catalytic 
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benzylquininium chloride led to the nitro compound 6a (72%). Replacing potassium by cesium 
hydroxide led to incomplete reaction after 48 h, in contrast to one of the earlier reports. The nitro 
compound prepared by this route was formed highly stereoselectively, whereas the route from S-
valine was stereospecific. 
 
 
 
Scheme 4. Alternative preparation of R-nitromethylpropanamine 6a. Reagents: i, BocNH2, 
PhSO2Na, THF aq., 20 °C; ii, MeNO2, KOH, benzylquininium chloride (12 mol %), toluene, –
78→20 °C, 48 h. 
 
The next step was N-acetoacetylation of the amino-nitro compound 6a, which was initially 
attempted as described earlier, using thermolysis of the diketene-acetone adduct (pyridinium 
toluene-4-sulfonate, toluene reflux, 3 h), but starting material was recovered. As an alternative 
acylating agent we employed S-tert-butyl 3-oxobutanthioate 14, itself generated by base 
treatment of 2-methylpropane-2-thiol (NaH, THF, –15→0 °C) followed by addition of diketene 
to the thiolate at –5 °C.13 Thus amino-nitro compound 6a and the thioester 14 were reacted in the 
presence of silver(I) trifluoroacetate (THF in the dark) but starting carbamate 6a was 
recovered.14 We reasoned this was due to reduced nucleophilicity of the carbamate N-atom, so 
we removed the tert-butyloxycarbonyl group (TFA, followed by 2M hydrochloric acid) to afford 
the stable amine hydrochloride salt 15 (Scheme 5). Acylation was completed using both 
protocols described above, to afford the acetoacetamide 16 (68% from diketene-acetone adduct; 
just 19% from thioester 14). The precursor functionality for generation of the required dipole 
(nitrile oxide from dehydration of the primary nitro group) and dipolarophile (enamine derived 
from the β-ketoamide) is present in the acetoacetamide 16. The next step was planned to be the 
enamine formation, so the amide 16 was treated with pyrrolidine in toluene at reflux under Dean-
Stark water removal conditions. After workup, a product was recovered (55%) but the 1H NMR 
spectrum was missing the CH3 and CH signals expected for the enamine 17, although it did show 
signals for the pyrrolidine ring. The structure was revealed by an X-ray crystal structure 
determination to be the unexpected mixed urea 18 (Figure 2). The solid-state structure displays 
two independent molecules in the asymmetric unit, differing in the detailed conformation of the 
pyrrolidine sub-unit and linked via a strong N–H···O hydrogen bond.15 
Authors, we changed the "Figure 1" on page 5 to the "Figure 2" because you have the 
"Figure 1" on page 1. 
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Scheme 5. Attempted enamine formation from acetoacetamide 16. Reagents: i, TFA, 20 °C, 4.5 
h, then 2M HCl aq., 20 °C, 0.5 h; ii, Et3N, DCM, then 2,2,6-trimethyl-1,3-dioxin-4-one, pyrH+–
OTs, toluene reflux; iii, Et3N, DCM, then MeCOCH2COSBut 14, CF3CO2Ag, THF, –15 °C, 30 
min; iv, pyrrolidine, toluene, Dean-Stark reflux. 
 
 
 
Figure 2. X-Ray crystal structure of mixed urea 18. The structure comprises two independent 
molecules differing in conformation of the pyrrolidine unit. N(5)–H(5)···O(1): d(D...A) = 
2.917(2) Å, <(DHA) = 155(2)°; N(2)–H(2)...O(4'): d(D...A) = 2.889(2) Å, <(DHA) = 160(2)°, 
generating chains parallel to b; ' = −x,y+1/2,−z+1/2. 
 
We propose the mechanism shown in Scheme 6 wherein the iminium ion formed en route to 
the desired enamine 17, or in equilibrium with it, is attacked by a second pyrrolidine molecule to 
promote a retro-Claisen reaction, affording the observed urea and presumably the pyrrolidine 
enamine of propanone as an unusual leaving group, although this was not isolated. 
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Scheme 6. Possible mechanism for formation of mixed urea 18. 
 
An alternative potential sequence towards an intramolecular dipolar cycloaddition would be 
nitrile oxide formation and then cycloaddition to the enol form of the β-keto amide. With this in 
mind we treated the nitro compound 16 under several reported dehydration conditions: di-tert-
butyl dicarbonate16 or ethyl chloroformate17 (Et3N, 0.1 mol equiv. 4-DMAP, in DCM, 
acetonitrile or toluene at reflux), but in all cases starting material was recovered unchanged. 
Likewise, an attempt to form a silyl nitronate as dipole (TMSCl, Et3N, in THF or acetonitrile at 
reflux) returned starting nitro-amide 16. 
 
 
Conclusions    
 
In conclusion, based on these explorations we have not been able to form the isoxazole building 
block 2 via an intramolecular approach , and continued to focus instead on developing the 
pyrroloisoxazole strategy towards masked acyltetramic acids via the previously reported 
intermolecular sequence. 
 
  
Experimental Section     
 
General. Commercial dry solvents were used in all reactions except for light petroleum and 
EtOAc, distilled from CaCl2, and CH2Cl2 distilled over P2O5. THF was distilled from sodium and 
benzophenone. Light petroleum refers to the b.p. 40-60 °C fraction. Sodium hydride was 
obtained as 60% dispersion in oil and washed with light petroleum. Melting points were 
determined on a Leica Galen III hot stage apparatus. 1H (250 MHz), 1H (400 MHz) and 13C (100 
MHz) NMR spectra were recorded on Bruker AC-250 or AC-400 spectrometers in CDCl3 
solutions with Me4Si or (CD3)2SO as internal standard unless otherwise specified. Chemical 
shifts δ are given in parts per million (ppm) and 1H coupling constants J in Hz, with 
multiplicities: s (singlet), d (doublet), t (triplet) and m (multiplet). Mass spectra were recorded on 
a JEOL SX102 spectrometer, or carried out by the EPSRC National Mass Spectrometry Service 
Centre (Swansea) or on a ZQ2000 spectrometer with Waters 600 series liquid handling system, 
dual wavelength UV and ELS detectors at Novartis, Horsham UK. MicroMass LCT was detected 
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using a TOF spectrometer with Agilent 1100 series HPLC and Gilson 215 liquid handling; diode 
array and CAD detectors; Platform LC spectrometers with Agilent 1100 series HPLC diode array 
and ELS detectors; ThermoElectron LTQ Linear Quadrupole Ion Trap MS with ESI probe and 
APCI source were used for MS/MS; ThermoElectron DSQ MS with TRACE GC, at Novartis. 
GCMS was carried out on a Fisons 8000 series instrument using a 15 m x 0.25 mm DB-5 column 
and an EI low resolution MS at Novartis. IR spectra were recorded on a Perkin-Elmer Paragon 
1000 FT-IR spectrophotometer on NaCl plates, in the range 4000–600 cm–1. Elemental analyses 
were determined on a Perkin Elmer 2400 CHN Elemental Analyser in conjunction with a Perkin 
Elmer AD-4 Autobalance, or on a LECO CHNS-932 Analyser, at Novartis. TLC using silica gel 
as absorbent was carried out on aluminium backed plates coated with silica gel (Merck Kieselgel 
60 F254), and TLC using alumina as absorbent was carried out on aluminium backed plates 
coated with neutral aluminium oxide (Merck 150 F254, Type T). Silica gel (Merck Kieselgel 60 H 
silica) was used for column chromatography unless otherwise specified. Column 
chromatography using alumina was carried out with Aldrich aluminium oxide, activated neutral, 
Brockmann 1, STD Grade, 150 mesh sizes. Preparative TLC was carried out using aluminium 
oxide (Merck 60 F254, Type E). 
 
S-2-tert-Butyloxycarbonylamino-3-methylbutanaldoxime (4a). DIBAL-H (1.0M in toluene, 
22 mL, 21.73 mmol) was added dropwise over 1 h to a suspension of N-tert-
butyloxycarbonylamino-S-valine methyl ester (2.0 g, 8.69 mmol) in dry toluene (10 mL) under 
nitrogen with stirring at –78 °C. After stirring the reaction mixture at –78 °C. for a further 30 
min, MeOH (approx. 7 mL) was added to the mixture and it was poured into a solution of 
Rochelle salt (50 g) in water (100 mL) and stirred vigorously for 2 h. The aqueous phase was 
separated, extracted with EtOAc (3 x 50 mL), and the combined organic layers were washed 
with saturated brine (2 x 50 mL), dried (MgSO4) and concentrated under reduced pressure to 
yield S-2-tert-butyloxycarbonylamino-3-methylbutanal (2.0 g, 100%) as a colourless oil that was 
used directly, IR (νmax, CHCl3/cm–1), 3350, 2967, 2931, 1700, 1367, 1248, 1044, 1019. 1H NMR 
(400 MHz; CDCl3), δH 0.94-1.04 (6H, 2 x d, J 6.8, CH(CH3)2), 1.45 (9H, s, C(CH3)3), 2.25-2.32 
(1H, m, CH(CH3)2), 4.24-4.28 (1H, m, CHNH), 5.14-5.21 (1H, d, J 8, CHNH), 9.64 (1H, broad, 
CHO). 13C NMR (100 MHz; CDCl3), δC 17.6, 18.9 (CH(CH3)2), 28.4 (C(CH3)3), 29.0 
(CH(CH3)2), 64.7 (CHNH), 78.9 (C(CH3)3), 155.9 (OCONH), 200.5 (CHO). 
To the crude aldehyde (1.5 g, 6.94 mmol) in EtOH (10 mL) was added hydroxylamine 
hydrochloride (0.96 g, 13.88 mmol) and NaOAc (2.28 g, 27.76 mmol) in water (10 mL). A few 
drops of EtOH were added to dissolve the precipitate and the solution was warmed to 70 °C for 
10 min, cooled and stored in a refrigerator overnight. The white precipitate formed was filtered. 
The remaining mixture was extracted with EtOAc (3 x 70 mL) and the combined organic layers 
were dried (MgSO4) and concentrated under reduced pressure to yield the title compound 4a 
(1.34 g, 89%) as a white solid, syn:anti 2:1, m.p. 117-124 °C, [α]D20 +23.4 (c 12.8, MeOH), IR 
(νmax Nujol/cm–1), 3342, 2955, 1722, 1682, 1459, 1376, 1312, 1016. 1H NMR (400 MHz; 
(CD3)2SO), δH 0.77-.0.83 (6H, 2 x d, J 7.2, CH(CH3)2), 1.37 (9H, s, C(CH3)3), 1.72-1.78 (1H, m, 
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CH(CH3)2), 4.50-4.58 (1H, dd, J 8, 14, CHNH), 6.50-6.52 (1H, d, J 8, CHNOH), 6.98-7.01 (1H, 
d, J 14, CHNH), 10.9 (1H, s, OH). 13C NMR (100 MHz; (CD3)2SO), δC 18.6, 18.7 (CH(CH3)2), 
28.2 (C(CH3)3), 39.4 (CH(CH3)2), 50.2 (CHNH), 79.0 (C(CH3)3), 149.9 (CHN), 155.2 (OCONH). 
HRMS: Calcd for C10H20N2O3: MH+ 215.1547; found: MH+, 217.1557. Anal. Calcd for 
C10H20N2O3: C, 55.53; H, 9.32; N, 12.95%, Found: C, 55.51; H, 9.14; N, 13.01%. 
S-2-Benzyloxycarbonylamino-3-methylbutanaldoxime (4b). Prepared by the same method as 
oxime 4a but using N-benzyloxycarbonylamino-S-valine methyl ester (18.3 g, 68.98 mmol) in 
dry toluene (100 mL) and DIBAL-H (1.0M in toluene, 173 ml, 172.4 mmol), and worked-up 
using MeOH (15 mL), Rochelle salt (150 g) in water (300 mL) to afford 2-
benzyloxycarbonylamino-3-methylbutanal (17.0 g, 100%) as a colourless oil that was used 
directly. 1H NMR (400 MHz; CDCl3), δH 0.92-1.03 (6H, 2 x d, J 6.8, CH(CH3)2), 2.27-2.35 (1H, 
m, CH(CH3)2), 4.31-4.34 (1H, dd, J 4.4, 7.8, CHNH), 5.11 (2H, s, CH2Ph), 5.46-5.47 (1H, d, J 
7.8, CHNH), 7.26-7.36 (5H, m, Ar-H), 9.62 (1H, s, CHO). 13C NMR (100 MHz; CDCl3), δC 
17.5, 18.9 (CH(CH3)2), 29.0 (CH(CH3)2), 65.0 (CHNH), 65.8 (CH2Ph), 128.2, 128.4, 128.5 (Ar-
CH), 136.1 (Ar-C), 156.4 (OCONH), 199.9 (CHO). 
The crude aldehyde (16.2 g, 68.85 mmol) was treated with hydroxylamine hydrochloride (9.57 g, 
137.71 mmol), NaOAc (22.59 g, 275.41 mmol) in water (50 mL) and worked up to afford the 
title compound 4b (16.8 g, 97%) as a white solid, syn:anti 2:1, mp 124-126 °C, [α]D20 +26 (c 10, 
MeOH). 1H NMR (400 MHz; (CD3)2SO), δH 0.83-0.87 (6H, 2 x d, J 6.8, CH(CH3)2), 1.73-1.82 
(1H, m, CH(CH3)2), 4.58-4.63 (1H, ddd, J 7.0, 8.8, 15.6, CHNH), 5.02 (2H, s, CH2Ph), 6.53-6.55 
(1H, d, J 7.0, CHNH), 7.31-7.39 (5H, m, Ar-H), 7.45-7.48 (1H, d, J 8.8, CHNH), 10.98 (1H, s, 
OH). 13C NMR (100 MHz; (CD3)2SO), δC 18.2, 18.7 (CH(CH3)2), 30.5 (CH(CH3)2), 50.7 
(CHNH), 65.3 (CH2Ph), 127.7, 127.8 128.3 (Ar-CH), 137.1 (Ar-C), 149.6 (CHN), 156.0 
(OCONH). HRMS: Calcd for C13H18N2O3: M+ 250.1317; found: M+ 250.1310. 
Attempted N-acylation of S-2-tert-butyloxycarbonylamino-3-methylbutanaldoxime (4a). S-
2-tert-Butyloxycarbonylamino-3-methylbutanaldoxime (0.2 g, 0.93 mmol) 4a was added to 
2,2,6-trimethyl-1,3-dioxin-4-one (145 mg, 133 µL, 1.02 mmol) in dry toluene (20 mL) and 
followed by PPTS (256 mg, 1.02 mmol). The mixture was heated under reflux for 3 h and then 
concentrated under reduced pressure. The residue was partitioned between EtOAc (30 mL) and 
water (30 mL) and the aqueous phase extracted with EtOAc (2 x 30 mL). The combined extracts 
were dried (MgSO4) and concentrated under reduced pressure. The residue was subjected to 
column chromatography eluting with light petroleum : EtOAc (1:3 v/v) to yield an orange oil 
(94.4 mg) identified as S-(1-hydroxy-3-oxobutanoylaminomethyl-2-methylpropyl)carbamic acid 
tert-butyl ester 5a based on its 1H NMR spectrum. A test with FeCl3 supported the assignment of 
a hydroxamate structure, but complete characterization was not possible. 1H NMR (400 MHz; 
CDCl3), δH 0.93-0.97 (6H, 2 x d, J 6.8, CH(CH3)2), 1.44 (9H, s, C(CH3)3), 1.77-1.82 (1H, m, 
CH(CH3)2), 2.28 (3H, s, CH3CO), 3.49 (2H, s, CH2), 3.66-3.68 (1H, m, CHNH), 4.11-4.24 (2H, 
m, CHCH2), 4.59-4.64 (1H, d, J 9.6 Hz, CHNH). 13C NMR (100 MHz; CDCl3), δC 18.4, 19.4 
(CH(CH3)2), 28.4 (C(CH3)3), 30.1 (CH(CH3)2), 30.2 (CH3CO), 49.9 (CH2), 54.6 (CHNH), 65.6 
(CH2), 79.9 (C(CH3)3), 155.8 (OCONH), 167.1 (CONOH), 200.6 (CH3CO). 
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Attempted N-acylation of S-2-benzyloxycarbonylamino-3-methylbutanaldoxime (4b). 
Method A. Performed by the same method as for S-2-tert-butyloxycarbonylamino-3-
methylbutanaldoxime 4a but using 2-benzyloxycarbonylamino-3-methylbutanaldoxime 4b (200 
mg, 0.80 mmol), 2,2,6-trimethyl-1,3-dioxin-4-one (125 mg, 115 µL, 0.88 mmol), dry toluene (20 
mL) and PPTS (221 mg, 0.88 mmol) to yield an orange oil (53.8 mg) identified as S-(1-hydroxy-
3-oxobutanoylaminomethyl-2-methylpropyl)carbamic acid benzyl ester 5b based on its 1H NMR 
spectrum. A test with FeCl3 supported the assignment of a hydroxamate structure, but complete 
characterization was not possible. 1H NMR (400 MHz; CDCl3), δH 0.83-0.87 (6H, 2 x d, J 7.2, 
CH(CH3)2), 1.69-1.76 (1H, m, CH(CH3)2), 2.14 (3H, s, CH3CO), 3.34 (2H, s, CH2), 3.62-3.68 
(1H, m, CHNH), 4.07-4.17 (2H, m, CHCH2), 4.94-4.96 (1H, d, J 9.6, CHNH), 5.02 (2H, s, 
CH2Ph), 7.22-7.29 (5H, m, Ar-H). 13C NMR (100 MHz; CDCl3), δC 18.5, 19.4 (CH(CH3)2), 29.6 
(CH(CH3)2), 30.4 (CH3), 49.9 (CH2), 55.4 (CHNH), 67.0 (CH2), 68.1 (CH2Ph), 128.3, 128.5, 
128.8 (Ar-CH), 136.6 (Ar-C), 156.4 (OCONH), 172.4 (CONOH), 200.6 (CH3CO). 
Method B. Performed as Method A but using 2-benzyloxycarbonylamino-3-
methylbutanaldoxime 4b (500 mg, 2.00 mmol) and diketene (180 mg, 160 µL, 2.10 mmol) in dry 
toluene (20 mL) to yield a yellow oil (94.6 mg) whose NMR data were identical to a sample 
prepared by Method A above. 
S-(1-Hydroxymethyl-2-methylpropyl)carbamic acid tert-butyl ester (9a). Di-tert-butyl 
dicarbonate (2.22 g, 10.18 mmol) in CH2Cl2 (10 mL) was added dropwise to S-valinol 7 (1.0 g, 
9.69 mmol) in CH2Cl2 (25 mL) at 0 °C. Et3N (1.03 g, 1.42 mL, 10.18 mmol) was then added 
dropwise to the reaction mixture.  The mixture was stirred at 20 °C for 17 h, washed with citric 
acid solution (1M, 50 mL) and saturated brine (2 x 50 mL), dried (MgSO4) and concentrated 
under reduced pressure to afford a colourless oil that was purified by column chromatography 
eluting with light petroleum : EtOAc (2:1 v/v) to yield the title compound 9a (1.31 g, 66%) as a 
colourless oil, [α]D20 –24.8 (c 10, CHCl3), lit.10 [α]D20 –17 (c 1.68, CHCl3), IR (νmax CHCl3/cm–1), 
3337, 3032, 2962, 1714, 1315, 1234, 1150. 1H NMR (400 MHz; CDCl3), δH 0.88-0.92 (6H, 2 x 
d, J 6.8, CH(CH3)2), 1.40 (9H, s, C(CH3)3), 1.75-1.86 (1H, m, CH(CH3)2), 3.01 (1H, br, OH), 
3.33-3.41 (1H, m, CHNH), 3.51-3.68 (1H, m, CHCH2), 4.80-4.89 (1H, broad, CHNH). 13C NMR 
(100 MHz; CDCl3), δC 18.5, 19.5 (CH(CH3)2), 28.4 (C(CH3)3), 29.2 (CH(CH3)2), 59.2 (CHNH), 
63.2 (CHCH2), 79.4 (C(CH3)3), 156.8 (OCONH). HRMS: Calcd for C10H21NO3: MH+ 204.1594; 
found: MH+ 204.1589. 
S-(1-Hydroxymethyl-2-methylpropyl)carbamic acid benzyl ester (9b). Benzyl chloroformate 
(1.82 g, 1.52 ml, 10.66 mmol) was added dropwise to a bi-phase solution of S-valinol 7 (1 g, 
9.69 mmol) and NaHCO3 (3.42 g, 40.71 mmol) in water (50 mL) and CH2Cl2 (50 mL) at 0 °C. 
The mixture was stirred for 17 h and the aqueous phase was then acidified to pH 1 with 2M 
hydrochloric acid and extracted with CH2Cl2 (2 x 50 mL). The combined extracts were washed 
with saturated brine (50 mL), dried (MgSO4) and concentrated under reduced pressure to afford a 
colourless oil that was purified by column chromatography eluting with light petroleum : EtOAc 
(2:1 v/v) to yield the title compound 9b (2.06 g, 90%) as a white solid, mp 50-52 °C, [α]D20 –
20.67 (c 12, CHCl3), IR (νmax CHCl3/cm–1), 3322, 3031, 2963, 2875, 1700, 1541, 1235, 1177. 1H 
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NMR (400 MHz; CDCl3), δH 0.89-0.94 (6H, 2 x d, J 6.8, CH(CH3)2), 1.80-1.87 (1H, m, 
CH(CH3)2), 2.96 (1H, br, OH), 2.45-2.51 (1H, m, CHNH), 3.58-3.68 (2H, m, CHCH2), 5.07-5.11 
(1H, m, CH2), 5.16-5.18 (1H, d, J 8.8, CHNH), 7.27-7.36 (5H, m, Ar-H). 13C NMR (100 MHz; 
CDCl3), δC 18.5, 19.5 (CH(CH3)2), 29.3 (CH(CH3)2), 58.6 (CHNH), 63.6 (CH2OH), 66.9 
(CH2Ph), 127.8, 128.2, 128.5 (Ar-CH), 136.5 (Ar-C), 157.2 (OCONH). HRMS: Calcd for 
C13H19NO3: MH+ 238.1438; found: MH+ 238.1447. 
S-2-tert-Butoxycarbonylamino-3-methylbutyl methanesulfonate (10a). Et3N (305 mg, 420 
µL, 3.01 mmol) was added to S-(1-hydroxymethyl-2-methylpropyl)carbamic acid tert-butyl ester 
9a (510 mg, 2.51 mmol) in CH2Cl2 (20 mL) at 0 °C under nitrogen followed by methanesulfonyl 
chloride (345 mg, 233 µl, 3.01 mmol). The mixture was stirred at 20 °C for 4 h, then washed 
with water (30 mL), citric acid solution (1M, 30 mL) and saturated brine (30 mL), dried 
(MgSO4) and concentrated under reduced pressure to yield the title compound 10a (735.1 mg, 
100%) as a white solid that was used directly. 1H NMR (400 MHz; CDCl3), δH 0.93-0.99 (6H, 2 
x d, J 6.8, CH(CH3)2), 1.44 (9H, s, (C(CH3)3), 1.83-1.88 (1H, m, CH(CH3)2), 3.02 (3H, s, SCH3), 
3.59-3.63 (1H, m, CHNH), 4.24-4.27 (2H, m, CHCH2), 4.64-4.65 (1H, br, CHNH). 13C NMR 
(100 MHz; CDCl3), δC 18.5, 19.4 (CH(CH3)2), 28.4 (C(CH3)3), 29.1 (CH(CH3)2), 37.4 (SCH3), 
58.2 (CHNH), 69.7 (CH2), 79.8 (C(CH3)3), 155.6 (OCONH). 
S-2-Benzyloxycarbonylamino-3-methylbutyl methanesulfonate (10b). Prepared as for S-2-
tert-Butoxycarbonylamino-3-methylbutyl methanesulfonate 10a but using Et3N (0.24 g, 0.32 
mL, 2.32 mmol), S-(1-hydroxymethyl-2-methylpropyl)carbamic acid benzyl ester 9b (0.5 g, 2.11 
mmol) in CH2Cl2 (20 mL) and methanesulfonyl chloride (0.27 g, 2.32 mmol) to yield the title 
compound 10b (0.62 g, 93%) as a white solid that was used directly. 1H NMR (400 MHz; 
CDCl3), δH 0.96-1.03 (6H, 2 x d, J 6.8, CH(CH3)2), 1.85-1.92 (1H, m, CH(CH3)2), 2.96 (3H, s, 
SCH3), 3.69-3.75 (1H, m, CHNH), 4.28-4.29 (2H, d, J 4.4, CHCH2), 4.85-4.88 (1H, d, J 9.2, 
CHNH), 5.11-5.12 (2H, s, CH2Ph), 7.30-7.37 (5H, m, Ar-H). 13C NMR (100 MHz; CDCl3), δC 
18.5, 19.4 (CH(CH3)2), 29.1 (CH(CH3)2), 37.4 (SCH3), 56.0 (CHNH), 67.0 (CH2), 69.4 (CH2Ph), 
128.2, 128.3, 128.6 (Ar-C), 136.4 (Ar-C), 156.1 (OCONH). 
4-(2-Propyl)oxazolidin-2-one (12). Method A. NaI (339 mg, 2.26 mmol) was added to S-2-tert-
butoxycarbonylamino-3-methylbutyl methanesulfonate 10a (199 mg, 0.71 mmol) in acetone (20 
mL). The mixture was heated under reflux for 17 h and then concentrated under reduced pressure 
to leave a residue that was partitioned between EtOAc (30 mL) and water (30 mL) and the 
aqueous phase was extracted with EtOAc (2 x 30 mL). The combined organic layers were 
washed with sodium thiosulfate solution (10 % w/v, 30 mL), water (30 mL) and saturated brine 
(30 mL), dried (Na2SO4) and concentrated under reduced pressure to yield the title compound 12 
(162 mg, 100%) as a white solid, mp 63-65 °C (lit.18 67-70 °C), [α]D20 +17.1 (c 12, CHCl3) [lit.18 
[α]D26 +16.5 (c 10.4, CHCl3)]. 1H NMR (400 MHz; CDCl3), δH 0.83-0.91 (6H, 2 x d, J 6.8, 
CH(CH3)2), 1.63-1.71 (1H, m, CH(CH3)2), 3.52-3.58 (1H, dd, J 6.4, 16.0, CHNH), 4.02-4.06 
(1H, dd, J 6.4, 8.7, CH2), 4.36-4.40 (1H, t, J 8.7, 16.0, CH2), 6.26 (1H, br, CHNH). 13C NMR 
(100 MHz; CDCl3), δC 18.1, 18.5 (CH(CH3)2), 33.1 (CH(CH3)2), 58.8 (CHNH), 69.0 (CHCH2), 
160.6 (OCONH). 
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When the same procedure was applied to S-2-benzyloxycarbonylamino-3-methylbutyl 
methanesulfonate 10b (64 mg, 0.2 mmol) using NaI (97 mg, 0.65 mmol) in acetone (10 mL), the 
title compound 12 (5mg, 7%) was isolated along with S-(1-iodomethyl-2-methylpropyl)carbamic 
acid benzyl ester 11b (29.6 mg, 42%), data as reported below. 
S-(1-Iodomethyl-2-methylpropyl)carbamic acid tert-butyl ester (11a). Method A. Iodine (2.75 
g, 10.82 mmol) was added to a suspension of polystyrene-triphenylphosphine (5.19 g, 10.33 
mmol) in CH2Cl2 (100 mL) and the mixture stirred at 20 °C under nitrogen for 15 min.  
Imidazole (827 mg, 12.30 mmol) was then added and the mixture stirred for 15 min before S-(1-
hydroxymethyl-2-methylpropyl)carbamic acid tert-butyl ester 9a (1.0 g, 4.92 mmol) was added 
and the mixture heated under reflux for 20 h, then cooled and filtered. The filtrate was washed 
with sodium thiosulfate solution (10% w/v, 70 mL), water (70 mL) and saturated brine (70 mL). 
The organic layer was dried (Na2SO4) and concentrated under reduced pressure to afford a 
yellow solid (897 mg) that was purified by column chromatography eluting with light petroleum 
: EtOAc (2:1 v/v) to yield the title compound 11a (668 mg, 43%) as a yellow solid, mp 62-65 °C 
(lit.10 mp 48-51 °C), [α]D20 –20.8 (c 12.5, CHCl3) [lit.10 [α]D20 –18.7 (c 2.1, CHCl3)], IR (νmax 
CHCl3/cm–1), 3292, 2962, 2870, 1691, 1365, 1258, 1168. 1H NMR (400 MHz; CDCl3), δH 0.92-
0.97 (6H, 2 x d, J 6.8, CH(CH3)2), 1.45 (9H, s, C(CH3)3), 1.75-1.80 (1H, m, CH(CH3)2), 3.09-
3.13 (1H, m, CHNH), 3.31-3.35 (1H, dd, J 4.8, 10.4, CHCHH), 3.40-3.43 (1H, dd, J 3.6, 10.4, 
CHCHH), 4.53-4.58 (1H, br, CHNH). 13C NMR (100 MHz; CDCl3), δC 12.5 (CHCH2), 17.9, 
18.3 (CH(CH3)2), 27.3 (C(CH3)3), 31.3 (CH(CH3)2), 54.4 (CHNH), 78.9 (C(CH3)3), 159.1 
(OCONH). HRMS: Calcd for C10H20INO2: MH+ 314.0613; found: MH+ 314.0627. Anal. Calcd 
for C10H20INO2: C, 38.35; H, 6.44; N, 4.47%, Found: C, 38.67; H, 6.41; N, 4.73%. 
Method B. Iodine (2.75 g, 10.82 mmol) was added to triphenylphosphine (2.84 g, 10.82 mmol) in 
CH2Cl2 (100 mL) and the mixture stirred at 20 °C under nitrogen for 15 min. Imidazole (827 mg, 
12.30 mmol) was then added and the mixture stirred for 15 min before S-1-(hydroxymethyl-2-
methylpropyl)carbamic acid tert-butyl ester 9a (1 g, 4.92 mmol) was added and the mixture 
heated under reflux for 20 h, then worked up as method A to afford a yellow solid (3.74 g) that 
was purified by column chromatography eluting with light petroleum : EtOAc (2:1 v/v) to yield 
the title compound 11a as a yellow solid (471 mg, 31%) whose data were identical to those 
reported above. 
S-(1-Iodomethyl-2-methylpropyl)carbamic acid benzyl ester (11b). Prepared as in method A 
for S-(1-iodomethyl-2-methylpropyl)carbamic acid tert-butyl ester 11a but using iodine (2.35 g, 
8.85 mmol), polystyrene-triphenylphosphine (4.45 g, 8.85 mmol), imidazole (0.72 g, 10.54 
mmol) and S-(1-hydroxymethyl-2-methylpropyl)carbamic acid benzyl ester 9b (1 g, 4.21 mmol) 
to afford a yellow solid (1.26 g) that was purified by column chromatography eluting with light 
petroleum : EtOAc (2:1 v/v) to yield the title compound 11b (1.17 g, 80 %) as a light yellow 
solid, mp 76-77.5 °C, [α]D20 –22.5 (c 10.3, CHCl3), IR (νmax CHCl3/cm–1), 3338, 2960, 2872, 
1689, 1532, 1239, 1182. 1H NMR (400 MHz; CDCl3), δH 0.86-0.91 (6H, 2 x d, J 6.8, CH(CH3)2), 
1.68-1.77 (1H, m, CH(CH3)2), 3.08-3.15 (1H, m, CHNH), 3.26-3.30 (1H, dd, J 5.9, 10.4, 
CHCH2), 3.34-3.38 (1H, dd, J 4, 10.4, CHCH2), 4.72-4.75 (1H, d, J 8.4, CHNH), 5.04 (2H, s, 
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CH2Ph), 7.24-7.31 (5H, m, Ar-H). 13C NMR (100 MHz; CDCl3), δC 12.0 (CH2), 17.3, 18.2 
(CH(CH3)2), 31.3 (CH(CH3)2), 55.1 (CHNH), 65.9 (CH2Ph), 127.1, 127.2, 127.5 (Ar-CH), 136.4 
(Ar-C), 157.1 (OCONH). HRMS: Calcd for C13H18INO2: MH+ 348.0457; found: MH+ 348.0465. 
S-(2-Methyl-1-nitromethylpropyl)carbamic acid tert-butyl ester (6a). NaNO2 (490 mg, 7.09 
mmol), phloroglucinol (447 mg, 3.55 mmol) and urea (490 mg, 7.09 mmol) were added to S-(1-
iodomethyl-2-methylpropyl)carbamic acid tert-butyl ester 11a (1.01 g, 3.22 mmol) in dry DMF 
under nitrogen, the mixture was stirred at 20 °C for 20 h and washed with water (30 mL), sodium 
thiosulfate solution (10% w/v, 30 mL), water (30 mL), KHCO3 solution (10% w/v, 30 mL) and 
saturated brine (30 ml). The organic layer was dried (Na2SO4) and concentrated under reduced 
pressure to afford a yellow solid (998 mg) that was purified by column chromatography eluting 
with light petroleum : EtOAc (2:1 v/v) to yield the title compound 6a (487 mg, 64%) as a light 
yellow solid, mp 84-86.5 °C (lit.12a 80-83 °C for R-isomer), [α]D20 –24 (c 10, CHCl3) [lit.12a 
[α]D25 +34.8 (c 1.0, CH2Cl2) for R-isomer], IR (νmax CHCl3/cm–1), 3349, 2979, 1681, 1536, 1369, 
1248, 1163. 1H NMR (400 MHz; CDCl3), δH 0.89-0.94 (6H, 2 x d, J 7.2, CH(CH3)2), 1.37 (9H, s, 
C(CH3)3), 1.78-1.87 (1H, m, CH(CH3)2), 3.87-3.90 (1H, m, CHNH), 4.54-4.57 (2H, m, CHCH2), 
4.73-4.76 (1H, br, CHNH). 13C NMR (100 MHz; CDCl3), δC 18.5, 19.5 (CH(CH3)2), 28.3 
(C(CH3)3), 30.0 (CH(CH3)2, 55.0 (CHNH), 74.5 (CHCH2), 79.8 (C(CH3)3), 155.6 (OCONH). 
HRMS: Calcd for C10H20N2O4: MH+ 233.1496; found: MH+ 233.1504. 
S-(2-Methyl-1-nitromethylpropyl)carbamic acid benzyl ester (6b). Prepared as for S-(2-
methyl-1-nitromethylpropyl)carbamic acid tert-butyl ester 6a but using NaNO2 (430 mg, 6.24 
mmol), phloroglucinol (393 mg, 3.12 mmol), urea (374 mg, 6.24 mmol) and S-(1-iodomethyl-2-
methylpropyl)carbamic acid benzyl ester 11b (984 mg, 2.83 mmol) to afford a yellow solid (862 
mg) that was purified by column chromatography eluting with light petroleum : EtOAc (2:1 v/v) 
to yield the title compound 6b (628 mg, 70%) as a light yellow solid, mp 66 °C, [α]D20 –32.4 (c 
10, CHCl3), IR (νmax CHCl3/cm–1), 3324, 2964, 1696, 1554, 1381, 1244. 1H NMR (400 MHz; 
CDCl3), δH 0.91-0.95 (6H, 2 x d, J 6.8, CH(CH3)2), 1.82-1.87 (1H, m, CH(CH3)2), 3.91-4.00 (1H, 
m, CHNH), 4.46-4.52 (2H, m, CHCH2), 4.98-5.02 (1H, br, CHNH), 5.04 (2H, s, CH2Ph), 7.24-
7.32 (5H, m, Ar-H). 13C NMR (100 MHz; CDCl3), δC 19.1, 19.8 (CH(CH3)2), 30.4 (CH(CH3)2), 
55.6 (CHNH), 67.6 (CH2Ph), 78.9 (CHCH2), 128.6, 128.7, 129.0 (Ar-CH), 136.4 (Ar-C), 156.2 
(OCONH). HRMS: Calcd for C13H18N2O4: MH+ 267.1339; found: MH+ 267.1338. 
(1-Benzenesulfonyl-2-methylpropyl)carbamic acid tert-butyl ester (13). To tert-butyl 
carbamate (1.32 g, 11.27 mmol) in THF (4 mL) at 20 °C was added benzenesulfinic acid sodium 
salt (2.03 g, 12.39 mmol) in water (10 mL), followed by 2-methylpropanal (0.89 g, 1.13 mL, 
12.39 mmol) and then formic acid (2.5 mL). The mixture was stirred for 17 h and the white 
precipitate formed (3.68 g) was filtered and recrystallised from 2-methylpentane : EtOAc (4:1 
v/v) to yield the title compound 13 (2.64 g, 75%) as a white solid, mp 122.5-123.5 °C, IR (νmax 
CHCl3/cm–1), 3353, 2974, 1703, 1644, 1367, 1307, 1168, 1142, 1082. 1H NMR (400 MHz; 
CDCl3), δH 1.00-1.08 (6H, 2 x d, J 6.8, CH(CH3)2), 1.16 (9H, s, C(CH3)3), 2.68-2.76 (1H, m, 
CH(CH3)2), 4.66-4.69 (1H, dd, J 3.4, 11.2, CHNH), 5.04-5.07 (1H, d, J 11.2, CHNH), 7.48-7.57 
(3H, m, Ar-H), 7.82-7.84 (2H, d, J 7.4, Ar-H). 13C NMR (100 MHz; CDCl3), δC 17.3, 21.0 
General Papers  ARKIVOC 2013 (iii) 00-00 
Page 14 ©ARKAT-USA, Inc 
(CH(CH3)2), 27.3 (CH(CH3)2), 28.4 (C(CH3)3), 74.7 (CHNH), 81.2 (C(CH3)3), 129.3, 129.6, 
134.1 (Ar-CH), 138.5 (Ar-C), 154.5 (OCONH). HRMS: Calcd for C15H23NO4S: MH+ 314.1420; 
found: MH+ 314.1434. Anal. Calcd for C15H23NO4S: C, 57.48; H, 7.40; N, 4.47, S, 10.23%, 
Found: C, 57.28; H, 7.69; N, 4.71; S, 9.93%. 
R-(2-Methyl-1-nitromethylpropyl)carbamic acid tert-butyl ester (6c). N-Benzylquininium 
chloride (35 mg, 0.08 mmol, 12 mol %) was added to (1-benzenesulfonyl-2-
methylpropyl)carbamic acid tert-butyl ester 13 (200 mg, 0.64 mmol) and KOH (186 mg, 3.32 
mmol) in toluene (5 mL) at –78 °C under nitrogen. Nitromethane (203 mg, 180 µL, 3.32 mmol) 
was added dropwise and the mixture allowed to reach 20 °C and stirred for 48 h. The mixture 
was concentrated under reduced pressure, the residue partitioned between EtOAc (30 mL) and 
water (30 mL) and the aqueous layer extracted with EtOAc (2 x 30 mL). The combined organic 
layers were washed with water (30 mL) and saturated brine (30 mL), dried (MgSO4) and 
concentrated under reduced pressure to yield a yellow oil (151 mg) that was purified by column 
chromatography eluting with EtOAc : 2-methylpentane (2:3 v/v) to yield the title compound 6c 
(107 mg, 72%) as a light yellow solid, data identical to those reported above for S-isomer 6a 
with the exception of an opposite sign of optical rotation, [α]D20 +25 (c 10, CHCl3) [lit.12a [α]D25 
+34.8 (c 1.0, CH2Cl2)]. 
S-2-Methyl-1-nitromethylpropylamine hydrochloride (15). TFA (14.82 g, 9.66 mL, 130.01 
mmol) was added to S-(2-methyl-1-nitromethylpropyl)carbamic acid tert-butyl ester 6a (1.51 
mg, 6.50 mmol), the mixture was stirred at 20 °C for 4.5 h and then concentrated under reduced 
pressure. Hydrochloric acid (2M, 65 mL, 130.01 mmol) was added to the residue and the mixture 
was stirred at 20 °C for 0.5 h and then concentrated under reduced pressure to leave a residue 
that was dissolved in water (30 mL) and washed with EtOAc (2 x 30 mL). The aqueous phase 
was evaporated to dryness to yield the title compound 15 (0.99 g, 90%) as a light yellow solid, 
mp 137-141 °C, [α]D20 –11.2 (c 10, MeOH), IR (νmax CHCl3/cm–1), 3424, 2974, 1558. 1H NMR 
(400 MHz; (CD3)2SO), δH 0.94-0.98 (6H, 2 x d, J 6.8, CH(CH3)2), 2.00-2.05 (1H, m, CH(CH3)2), 
3.67-3.71 (1H, m, CHNH), 4.77-4.79 (1H, dd, J 8, 15.4, CHCHH), 4.96-4.97 (1H, dd, J 3.2, 
15.4, CHCHH), 8.48 (3H, br, NH3). 13C NMR (100 MHz; (CD3)2SO), δC 17.4, 18.1 (CH(CH3)2), 
28.2 (CH(CH3)2), 52.9 (CHNH), 74.3 (CHCH2). HRMS: Calcd for C5H12N2O2: MH+ 133.0971; 
found: MH+ 133.0977. 
N-(S-2-Methyl-1-nitromethylpropyl)-3-oxobutanamide (16). Et3N (937 mg, 1.29 mL, 9.26 
mmol) was added to S-2-methyl-1-nitromethylpropylamine hydrochloride 15 (1.42 g, 8.42 
mmol) in CH2Cl2 (20 mL), the mixture stirred at 20 °C for 30 min then concentrated under 
reduced pressure to afford a residue that was dissolved in toluene (25 mL) and 2,2,6-trimethyl-
1,3-dioxin-4-one (1.32 g, 1.21 mL, 9.26 mmol) and PPTS (2.33 g, 9.26 mmol, 1.1 eq) were 
added. The mixture was heated at reflux under Dean-Stark conditions for 3 h and then 
concentrated under reduced pressure to leave a residue that was partitioned between water (30 
mL) and EtOAc (30 mL) and the aqueous phase was extracted with EtOAc (2 x 30 mL). The 
combined organic extracts were washed with saturated NaHCO3 solution (30 mL) and saturated 
brine (30 mL), dried (MgSO4) and concentrated under reduced pressure to afford a brown oil 
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(2.38 g) that was purified by column chromatography eluting with light petroleum : EtOAc (1:2 
v/v) to yield the title compound 16 (1.23 g, 68%) as a brown oil, [α]D20 –36 (c 10, CHCl3), IR 
(νmax CHCl3/cm–1), 3299, 3073, 2966, 1716, 1556, 1382. 1H NMR (400 MHz; CDCl3), δH 0.99-
1.03 (6H, 2 x d, J 7.2, CH(CH3)2), 1.92-1.98 (1H, m, CH(CH3)2), 2.28 (3H, s, CH3CO), 3.42 (2H, 
s, COCH2), 4.32-4.39 (1H, m, CHNH), 4.52-4.56 (1H, dd, J 4.8, 12.6, CHCHH), 4.56-4.61 (1H, 
dd, J 6.8, 12.6, CHCHH), 7.44-7.46 (1H, d, J 7.6, CHNH). 13C NMR (100 MHz; CDCl3), δC 
18.5, 19.4 (CH(CH3)2), 29.7 (CH(CH3)2), 31.2 (CH3CO), 48.9 (CHCH2), 53.2 (CHNH), 76.5 
(COCH2), 165.6 (CONH), 204.8 (CO). HRMS: Calcd for C9H16N2O4: MH+ 217.1183; found: 
MH+ 217.1188. 
N-(S-2-Methyl-1-nitromethylpropyl)-N’-(tetramethylenyl)urea (18). To N-(S-2-methyl-1-
nitromethylpropyl)-3-oxobutanamide 16 (48 mg, 0.22 mmol) in toluene (20 mL) was added 
pyrrolidine (18 mg, 20 µl, 0.24 mmol) dropwise and the mixture heated to reflux under Dean-
Stark conditions for 3 h, then cooled and the solvent removed under reduced pressure. The 
residue was partitioned between water (30 mL) and EtOAc (30 mL), the aqueous phase extracted 
with EtOAc (2 x 30 mL) and the combined organic layers were dried (MgSO4) and concentrated 
under reduced pressure to leave a dark brown oil (163 mg) that was purified by column 
chromatography eluting with light petroleum : EtOAc (1:2 v/v) to yield the title compound 18 
(28 mg, 55%) as a brown oil, recrystallised from Et2O–hexane to afford colourless crystals, 
[α]D20 –6.96 (c 10, CHCl3), IR (νmax CHCl3/cm–1), 3423, 2964, 2872, 1635, 1552. 1H NMR (400 
MHz; CDCl3), δH 0.99-1.04 (6H, 2 x d, J 6.8, CH(CH3)2), 1.86-1.94 (5H, m, CH(CH3)2 & 2 x 
CH2), 3.33-3.36 (4H, m, 2 x NCH2), 4.06-4.13 (1H, m, CHNH), 4.56-4.60 (2H, dd & br, J 4, 
12.4, CHCHH
 
& CHNH), 4.65-4.69 (1H, dd, J 5.6, 12.4, CHCHH). 1H NMR (100 MHz; 
CDCl3), δC 19.3, 19.6 (CH(CH3)2), 25.5 (CH2), 30.0 (CH(CH3)2), 45.5 (NCH2), 54.5 (CHNH), 
76.7 (CHCH2), 155.8 (NCON). HRMS: Calcd for C10H19N3O3: MH+ 230.1499; found: MH+ 
230.1499. 
Crystal data for urea (18). C10H19N3O3, M = 229.28, orthorhombic, a = 9.3464(17), b = 
14.504(3), c = 18.094(3) Å, U = 2453.0(8) Å3, T = 150(2) K, space group P212121, Mo-Kα 
radiation, λ = 0.71073 Å, Z = 8, Dc = 1.242 Mg m–3, F(000) = 992, crystal dimensions 0.47 × 
0.15 × 0.09 mm, µ(Mo-Kα) = 0.092 mm–1, 3.60 < 2θ < 56.66°, 25509 reflections measured,19 
3449 unique reflections. Solved by direct methods and refined by full-matrix least-squares on 
F2.20 The final cycle (for 299 parameters) converged with wR2 = 0.0969 (for all data) and R1 = 
0.0393 [F2 > 2σ]. Friedel pairs were merged due to the absence of any significant anomalous 
scattering. The enantiomer was assigned from an unchanging chiral centre {C(6) & C(15)}. 
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